NCT05348928View on ClinicalTrials.gov

A Pilot Study of the Feasibility and Accuracy of the TrueVie CGM System - A Non-Significant Risk Study

CompletedOBSERVATIONAL
Enrollment

16

Participants

Timeline

Start Date

May 4, 2022

Primary Completion Date

June 16, 2022

Study Completion Date

June 16, 2022

Conditions
Continuous Glucose Monitoring
Interventions
DEVICE

Continuous glucose monitoring device

Continuous glucose monitoring device

OTHER

Laboratory plasma glucose concentration determination

Laboratory plasma glucose concentration determination

Trial Locations (1)

98057

Rainier Clinical Research Center, Renton

Sponsors
All Listed Sponsors
collaborator

Integrated Medical Development

INDUSTRY

lead

Sinocare Meditech Inc.

INDUSTRY